Critical assessment of human antibody generation in humanized mouse models

Journal of Immunological Methods

Volumn 410, Issue , 2014, Pages 18-27

  Villaudy, Julien ^a,b   Schotte, Remko ^a   Legrand, Nicolas ^c   Spits, Hergen ^a,b  

^a AIMM Therapeutics BV   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c INSTITUT PASTEUR   (France)

Author keywords

Antibody; B cell; Human immune system mouse; Humoral immune response

Indexed keywords

CD5 ANTIGEN; CYTOKINE; MONOCLONAL ANTIBODY; ANTIBODY;

ANTIBODY PRODUCTION; B LYMPHOCYTE; BONE MARROW; CELL INTERACTION; CELL MATURATION; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; INFECTION; MOUSE MODEL; NONHUMAN; PHENOTYPE; REVIEW; T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN IMMUNE SYSTEM MOUSE; IMMUNOLOGY; MOUSE; XENOGRAFT;

ANTIBODY; B CELL; HUMAN IMMUNE SYSTEM MOUSE; HUMORAL IMMUNE RESPONSE;

ANIMALS; ANTIBODIES; B-LYMPHOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HETEROGRAFTS; HUMANS; MICE; MODELS, IMMUNOLOGICAL;

EID: 84908548812     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.06.010     Document Type: Review

References (102)

1. An D., Poon B., Ho Tsong Fang R., Weijer K., Blom B., Spits H., Chen I., Uittenbogaart C. Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin. Vaccine Immunol. 2007, 14:391. 10.1128/CVI.00403-06.
2. Aydar Y., Sukumar S., Szakal A., Tew J. The influence of immune complex-bearing follicular dendritic cells on the IgM response, Ig class switching, and production of high affinity IgG. J. Immunol. 2005, 174:5358.
3. -/- mice. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15951. 10.1073/pnas.0604493103.
4. Baumgarth N., Tung J., Herzenberg L. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 2005, 26:347. 10.1007/s00281-004-0182-2.
5. Becker P., Legrand N., van Geelen C.M., Noerder M., Huntington N., Lim A., Yasuda E., Diehl S., Scheeren F., Ott M., Weijer K., Wedemeyer H., Di Santo J., Beaumont T., Guzman C., Spits H. Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice. PLoS One 2010, 5. 10.1371/journal.pone.0013137.
6. Bertrand F., Billips L., Burrows P., Gartland G., Kubagawa H., Schroeder H. Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow. Blood 1997, 90:736.
7. + B cells. Immunology 2011, 134:419. 10.1111/j.1365-2567.2011.03501.x.
8. Blom B., Spits H. Development of human lymphoid cells. Annu. Rev. Immunol. 2006, 24:287. 10.1146/annurev.immunol.24.021605.090612.
9. Brainard D., Seung E., Frahm N., Cariappa A., Bailey C., Hart W., Shin H.-S., Brooks S., Knight H., Eichbaum Q., Yang Y.-G., Sykes M., Walker B., Freeman G., Pillai S., Westmoreland S., Brander C., Luster A., Tager A. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J. Virol. 2009, 83:7305. 10.1128/JVI.02207-08.
10. Cao X., Shores E., Hu-Li J., Anver M., Kelsall B., Russell S., Drago J., Noguchi M., Grinberg A., Bloom E. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223.
11. Chan A., Carter P. Therapeutic antibodies for autoimmunity and inflammation. Nat. Rev. Immunol. 2010, 10:301. 10.1038/nri2761.
12. Chang H., Biswas S., Tallarico A., Sarkis P., Geng S., Panditrao M., Zhu Q., Marasco W. Human B-cell ontogeny in humanized NOD/SCID γc(null) mice generates a diverse yet auto/poly- and HIV-1-reactive antibody repertoire. Genes Immun. 2012, 13:399. 10.1038/gene.2012.16.
13. Chappaz S., Finke D. The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes. J. Immunol. 2010, 184:3562. 10.4049/jimmunol.0901647.
14. Chen Q., He F., Kwang J., Chan J., Chen J. GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J. Immunol. 2012, 189:5223. 10.4049/jimmunol.1201789.
15. Choi B., Chun E., Kim M., Kim S.-T., Yoon K., Lee K.-Y., Kim S. Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγ(null) (NSG) mice conditioned by busulfan. J. Clin. Immunol. 2011, 31:253. 10.1007/s10875-010-9478-2.
16. Covens K., Verbinnen B., Geukens N., Meyts I., Schuit F., Van Lommel L., Jacquemin M., Bossuyt X. Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype. Blood 2013, 121:5176. 10.1182/blood-2012-12-471953.
17. Cox J., Mota J., Sukupolvi-Petty S., Diamond M., Rico-Hesse R. Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J. Virol. 2012, 86:7637. 10.1128/JVI.00534-12.
18. Cuss A., Avery D., Cannons J., Yu L., Nichols K., Shaw P., Tangye S. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J. Immunol. 2006, 176:1506.
19. Cyster J. Lymphoid organ development and cell migration. Immunol. Rev. 2003, 195:5. 10.1034/j.1600-065X.2003.00075.x.
20. Danner R., Chaudhari S., Rosenberger J., Surls J., Richie T., Brumeanu T.-D., Casares S. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One 2011, 6. 10.1371/journal.pone.0019826.
21. + cells. Blood 1997, 90:4014.
22. Dorshkind K., Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat. Rev. Immunol. 2007, 7:213. 10.1038/nri2019.
23. Drake A., Chen Q., Chen J. Engineering humanized mice for improved hematopoietic reconstitution. Cell. Mol. Immunol. 2012, 9:215. 10.1038/cmi.2012.6.
24. Fu Y., Molina H., Matsumoto M., Huang G., Min J., Chaplin D. Lymphotoxin-alpha (LTalpha) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 1997, 185:2111. 10.1084/jem.185.12.2111.
25. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 1993, 177:999. 10.1084/jem.177.4.999.
26. Ghia P., ten Boekel E., Sanz E., de la Hera A., Rolink A., Melchers F. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci. J. Exp. Med. 1996, 184:2217. 10.1084/jem.184.6.2217.
27. -/- mice: functional inactivation of p53 in developing T cells. Blood 2004, 104:3886. 10.1182/blood-2004-02-0656.
28. Goodnow C., Sprent J., Fazekas de St Groth B., Vinuesa C. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005, 435:590. 10.1038/nature03724.
29. -/- mice. J. Virol. 2007, 81:2700. 10.1128/JVI.02010-06.
30. Greenblatt M., Vbranac V., Tivey T., Tsang K., Tager A., Aliprantis A. Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. PLoS One 2012, 7. 10.1371/journal.pone.0044664.
31. + CD70. J. Exp. Med. 2011, 208:67. 10.1084/jem.20101499.
32. Halverson R., Torres R., Pelanda R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 2004, 5:645. 10.1038/ni1076.
33. Heath S., Tew J., Tew J., Szakal A., Burton G. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995, 377:740. 10.1038/377740a0.
34. Hess J., Werner A., Wirth T., Melchers F., Jäck H., Winkler T. Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1745. 10.1073/pnas.98.4.1745.
35. Honjo T., Kinoshita K., Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 2002, 20:165.
36. Ippolito G., Hoi K., Reddy S., Carroll S., Ge X., Rogosch T., Zemlin M., Shultz L., Ellington A., Vandenberg C., Georgiou G. Antibody repertoires in humanized NOD-scid-IL2Rγ(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS One 2012, 7. 10.1371/journal.pone.0035497.
37. Ishikawa F., Yasukawa M., Lyons B., Yoshida S., Miyamoto T., Yoshimoto G., Watanabe T., Akashi K., Shultz L., Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005, 106:1565. 10.1182/blood-2005-02-0516.
38. Ito M., Hiramatsu H., Kobayashi K., Suzue K., Kawahata M., Hioki K., Ueyama Y., Koyanagi Y., Sugamura K., Tsuji K., Heike T., Nakahata T. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175. 10.1182/blood-2001-12-0207.
39. Ito R., Takahashi T., Katano I., Ito M. Current advances in humanized mouse models. Cell. Mol. Immunol. 2012, 9:208. 10.1038/cmi.2012.2.
40. Jaiswal S., Pearson T., Friberg H., Shultz L., Greiner D., Rothman A., Mathew A. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS One 2009, 4. 10.1371/journal.pone.0007251.
41. Jaiswal S., Pazoles P., Woda M., Shultz L., Greiner D., Brehm M., Mathew A. Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice. Immunology 2012, 136:334. 10.1111/j.1365-2567.2012.03585.x.
42. Kalscheuer H., Danzl N., Onoe T., Faust T., Winchester R., Goland R., Greenberg E., Spitzer T., Savage D., Tahara H., Choi G., Yang Y.-G., Sykes M. A model for personalized in vivo analysis of human immune responsiveness. Sci. Transl. Med. 2012, 4. 10.1126/scitranslmed.3003481.
43. Kametani Y., Shiina M., Katano I., Ito R., Ando K., Toyama K., Tsukamoto H., Matsumura T., Saito Y., Ishikawa D., Taki T., Ito M., Imai K., Tokuda Y., Kato S., Tamaoki N., Habu S. Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse. Exp. Hematol. 2006, 34:1240. 10.1016/j.exphem.2006.05.006.
44. - inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J. Immunol. 2005, 174:6686.
45. King M., Covassin L., Brehm M., Racki W., Pearson T., Leif J., Laning J., Fodor W., Foreman O., Burzenski L., Chase T., Gott B., Rossini A., Bortell R., Shultz L., Greiner D. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin. Exp. Immunol. 2009, 157:104. 10.1111/j.1365-2249.2009.03933.x.
46. Krautler N., Kana V., Kranich J., Tian Y., Perera D., Lemm D., Schwarz P., Armulik A., Browning J., Tallquist M., Buch T., Oliveira-Martins J., Zhu C., Hermann M., Wagner U., Brink R., Heikenwalder M., Aguzzi A. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 2012, 150:194. 10.1016/j.cell.2012.05.032.
47. -/-) (RAG-hu) mice. Virology 2007, 369:143. 10.1016/j.virol.2007.06.005.
48. Kwakkenbos M., Bakker A., van Helden P., Wagner K., Yasuda E., Spits H., Beaumont T. Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire. Methods 2013, 10.1016/j.ymeth.2013.07.002.
49. Kwant-Mitchell A., Ashkar A., Rosenthal K. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J. Virol. 2009, 83:10664. 10.1128/JVI.02584-08.
50. + cell transplantation. Blood 2006, 108:487. 10.1182/blood-2005-11-4388.
51. Lang J., Kelly M., Freed B., McCarter M., Kedl R., Torres R., Pelanda R. Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J. Immunol. 2013, 190:2090. 10.4049/jimmunol.1202810.
52. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985, 314:537. 10.1038/314537a0.
53. -/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. Blood 2013, 122:4013. 10.1182/blood-2013-06-506949.
54. LeBien T. Fates of human B-cell precursors. Blood 2000, 96:9.
55. Lee E.C., Owen M. The application of transgenic mice for therapeutic antibody discovery. Methods Mol. Biol. 2012, 901:137. 10.1007/978-1-61779-931-0_8.
56. Legrand N., Huntington N., Nagasawa M., Bakker A., Schotte R., Strick-Marchand H., de Geus S., Pouw S., Böhne M., Voordouw A., Weijer K., Di Santo J., Spits H. Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:13224. 10.1073/pnas.1101398108.
57. -/-, and C.B-17-scid/bg immunodeficient mice. Hum. Immunol. 2009, 70:790. 10.1016/j.humimm.2009.06.005.
58. Löffert D., Ehlich A., Müller W., Rajewsky K. Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development. Immunity 1996, 4:133. 10.1016/S1074-7613(00)80678-0.
59. Mackay F., Schneider P. Cracking the BAFF code. Nat. Rev. Immunol. 2009, 9:491. 10.1038/nri2572.
60. + cells. Exp. Hematol. 2003, 31:789. 10.1016/S0301-472X(03)00193-0.
61. Meier D., Bornmann C., Chappaz S., Schmutz S., Otten L., Ceredig R., Acha-Orbea H., Finke D. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 2007, 26:643. 10.1016/j.immuni.2007.04.009.
62. Melkus M., Estes J., Padgett-Thomas A., Gatlin J., Denton P., Othieno F., Wege A., Haase A., Garcia J. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 2006, 12:1316. 10.1038/nm1431.
63. Montecino-Rodriguez E., Dorshkind K. B-1 B cell development in the fetus and adult. Immunity 2012, 36:13. 10.1016/j.immuni.2011.11.017.
64. + B lymphoid cells in NOD/SCID mice. Stem Cells 1999, 17:242. 10.1002/stem.170242.
65. Pasare C., Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005, 438:364. 10.1038/nature04267.
66. Rajesh D., Zhou Y., Jankowska-Gan E., Roenneburg D., Dart M., Torrealba J., Burlingham W. Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice. Hum. Immunol. 2010, 71:551. 10.1016/j.humimm.2010.02.019.
67. Rajewsky K., Förster I., Cumano A. Evolutionary and somatic selection of the antibody repertoire in the mouse. Science 1987, 238:1088.
68. Rezk S., Nathwani B., Zhao X., Weiss L. Follicular dendritic cells: origin, function, and different disease-associated patterns. Hum. Pathol. 2013, 44:937. 10.1016/j.humpath.2012.10.005.
69. Robinet E., Baumert T. A first step towards a mouse model for hepatitis C virus infection containing a human immune system. J. Hepatol. 2011, 55:718. 10.1016/j.jhep.2011.02.038.
70. Rochman Y., Spolski R., Leonard W. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 2009, 9:480. 10.1038/nri2580.
71. Rongvaux A., Takizawa H., Strowig T., Willinger T., Eynon E., Flavell R., Manz M. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu. Rev. Immunol 2013, 10.1146/annurev-immunol-032712-095921.
72. Rook G. Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:18360. 10.1073/pnas.1313731110.
73. Rossi M., Medina K., Garrett K., Kolar G., Comp P., Shultz L., Capra J., Wilson P., Schipul A., Kincade P. Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice. J. Immunol. 2001, 167:3033.
74. + T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1. Vaccine 2010, 28(Suppl. 2):7. 10.1016/j.vaccine.2009.10.154.
75. + B cells. J. Exp. Med. 2008, 205:2033. 10.1084/jem.20070447.
76. Schmidt M., Appel M., Giassi L., Greiner D., Shultz L., Woodland R. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS One 2008, 3. 10.1371/journal.pone.0003192.
77. Seung E., Tager A. Humoral immunity in humanized mice: a work in progress. J. Infect. Dis. 2013, 208(Suppl. 2):9. 10.1093/infdis/jit448.
78. Sgro C. Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review. Toxicology 1995, 105:23. 10.1016/0300-483X(95)03123-W.
79. Shultz L., Lyons B., Burzenski L., Gott B., Chen X., Chaleff S., Kotb M., Gillies S., King M., Mangada J., Greiner D., Handgretinger R. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 2005, 174:6477.
80. Shultz L., Brehm M., Garcia-Martinez J., Greiner D. Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 2012, 12:786. 10.1038/nri3311.
81. Singh M., Singh P., Gaudray G., Musumeci L., Thielen C., Vaira D., Vandergeeten C., Delacroix L., Van Gulck E., Vanham G., de Leval L., Rahmouni S., Moutschen M. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses. PLoS One 2012, 7. 10.1371/journal.pone.0038491.
82. Sliwkowski M., Mellman I. Antibody therapeutics in cancer. Science 2013, 341:1192. 10.1126/science.1241145.
83. Small T., Keever C., Weiner-Fedus S., Heller G., O'Reilly R., Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990, 76:1647.
84. Song J., Willinger T., Rongvaux A., Eynon E., Stevens S., Manz M., Flavell R., Galán J. A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe 2010, 8:369. 10.1016/j.chom.2010.09.003.
85. + T cell depletion in humanized mice infected with HIV-1. J. Exp. Med. 2007, 204:705. 10.1084/jem.20062411.
86. Suzuki M., Takahashi T., Katano I., Ito R., Ito M., Harigae H., Ishii N., Sugamura K. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse. Int. Immunol. 2012, 24:243. 10.1093/intimm/dxs045.
87. Tan C., Broge T., Seung E., Vrbanac V., Viscidi R., Gordon J., Tager A., Koralnik I. Detection of JC virus-specific immune responses in a novel humanized mouse model. PLoS One 2013, 8. 10.1371/journal.pone.0064313.
88. Ter Meulen J. Monoclonal antibodies in infectious diseases: clinical pipeline in 2011. Infect. Dis. Clin. N. Am. 2011, 25:789. 10.1016/j.idc.2011.07.006.
89. Tew J., Wu J., Qin D., Helm S., Burton G., Szakal A. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol. Rev. 1997, 156:39. 10.1111/j.1600-065X.1997.tb00957.x.
90. Tezuka K., Xun R., Tei M., Ueno T., Tanaka M., Takenouchi N., Fujisawa J.-I. An animal model of adult T-cell leukemia-humanized mice with HTLV-1 specific immunity. Blood 2013, 10.1182/blood-2013-06-508861.
91. Tiegs S., Russell D., Nemazee D. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 1993, 177:1009. 10.1084/jem.177.4.1009.
92. Tonomura N., Habiro K., Shimizu A., Sykes M., Yang Y.-G. Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood 2008, 111:4293. 10.1182/blood-2007-11-121319.
93. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M., Murphy B., Rappuoli R., Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 2004, 10:871. 10.1038/nm1080.
94. Traggiai E., Chicha L., Mazzucchelli L., Bronz L., Piffaretti J.-C., Lanzavecchia A., Manz M. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304:104. 10.1126/science.1093933.
95. van Nierop K., de Groot C. Human follicular dendritic cells: function, origin and development. Semin. Immunol. 2002, 14:251. 10.1016/S1044-5323(02)00057-X.
96. Vuyyuru R., Patton J., Manser T. Human immune system mice: current potential and limitations for translational research on human antibody responses. Immunol. Res. 2011, 51:257. 10.1007/s12026-011-8243-9.
97. Wardemann H., Yurasov S., Schaefer A., Young J., Meffre E., Nussenzweig M. Predominant autoantibody production by early human B cell precursors. Science 2003, 301:1374. 10.1126/science.1086907.
98. Washburn M., Bility M., Zhang L., Kovalev G., Buntzman A., Frelinger J., Barry W., Ploss A., Rice C., Su L. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011, 140:1334. 10.1053/j.gastro.2011.01.001.
99. Watanabe S., Terashima K., Ohta S., Horibata S., Yajima M., Shiozawa Y., Dewan M., Yu Z., Ito M., Morio T., Shimizu N., Honda M., Yamamoto N. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007, 109:212. 10.1182/blood-2006-04-017681.
100. Watanabe Y., Takahashi T., Okajima A., Shiokawa M., Ishii N., Katano I., Ito R., Ito M., Minegishi M., Minegishi N., Tsuchiya S., Sugamura K. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int. Immunol. 2009, 21:843. 10.1093/intimm/dxp050.
101. Willinger T., Rongvaux A., Strowig T., Manz M., Flavell R. Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends Immunol. 2011, 32:321. 10.1016/j.it.2011.04.005.
102. Yajima M., Imadome K., Nakagawa A., Watanabe S., Terashima K., Nakamura H., Ito M., Shimizu N., Honda M., Yamamoto N., Fujiwara S. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J. Infect. Dis. 2008, 198:673. 10.1086/590502.